$MLYS
Mineralys Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$28.02
▲+0.14%+$0.040
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateMineralys Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is MLYS up today? It is at $28.02 (+0.14%), and our scanner flagged it 80 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment MLYS spikes, and full due diligence on MLYS — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $MLYS 80 times in the last 30 days. Create a free account to track $MLYS, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on MLYS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for MLYS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Karydas Daphne Director | Sold (automatic/other) | -3K | sold 33% | 6K | $86K at $28.58 | Sep 15, 26 |
Karydas Daphne Director | Other | 3K | added 48% | 9K | $36K at $12.02 | Sep 15, 26 |
Warren Eric Officer | Sold (automatic/other) | -7K | sold 16% | 38K | $193K at $25.98 | Aug 21, 26 |
Warren Eric Officer | Other | 7K | added 19% | 46K | $98K at $13.24 | Aug 21, 26 |
Rodman David Malcom Officer | Sold (automatic/other) | -2K | sold 4.1% | 51K | $59K at $27.09 | Aug 10, 26 |
Rodman David Malcom Officer | Other | 2K | added 4.2% | 54K | $35K at $16.00 | Aug 10, 26 |
Ferguson James J. Iii Officer | Acquired (grant/award) | +102K 0.1% of company | n/a | 102K | n/a | Aug 10, 26 |
Warren Eric Officer | Sold (automatic/other) | -7K | sold 16% | 38K | $200K at $26.87 | Jul 21, 26 |
Warren Eric Officer | Other | 7K | added 19% | 46K | $98K at $13.24 | Jul 21, 26 |
Rodman David Malcom Officer | Sold (automatic/other) | -416 | sold 0.8% | 51K | $11K at $26.53 | Jul 17, 26 |
Rodman David Malcom Officer | Other | 416 | added 0.8% | 52K | $6K at $15.44 | Jul 17, 26 |
Rodman David Malcom Officer | Sold (automatic/other) | -6K | sold 11% | 51K | $169K at $26.61 | Jul 15, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on MLYS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for MLYS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
MLYS last traded at $28.02, up 0.14% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Mineralys Therapeutics, Inc. Common Stock (MLYS) is next expected to report earnings on Monday, November 9, 2026, about 50 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The MLYS Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged MLYS 80 times in the last 30 days.
MLYS (Mineralys Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $2.48B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge MLYS for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$MLYS discussion
Sign in to ask a question or join the discussion.